TLR2 and Parkinson disease: There is evidence that suggests that the TLR2/TLR10 heterodimer mediates the proinflammatory response triggered by the binding of TLR2 to PAMPs of Listeria monocytogenes, Helicobacter pylori bacteria, influenza A virus, and molecular patterns associated with Parkinson’s disease [70].